Professor Sergio Sandrucci appointed RCE Steering Committee member for 2019-2020 14/02/2019
Following elections among the Rare Cancer Europe (RCE) partners, ESSO would like to congratulate Professor Sergio Sandrucci for his appointment as RCE Steering Committee member representing the Scientific societies and Healthcare providers group for the term 2019-2020.
Rare Cancers Europe (RCE) has been established as a partnership of cooperating organisations that work together to place the issue of rare cancers firmly on the European policy agenda, to identify and promote appropriate solutions and to exchange best practices. RCE is an initiative that brings together European stakeholders (currently 34 independent national and international organizations, societies, groups, networks, institutions and companies) with a common aim and commitment to raise awareness about the burden of rare cancers and to tackle rare cancers as an EU health priority. The European Society for Medical Oncology (ESMO) leads the initiative and runs its Secretariat. The RCE Steering committee consists of the RCE Chair, Prof. Paolo Casali, and 5 elected members representingtheir stakeholder group.
- Representative appointed by ESMO – Paolo Casali, RCE Chair
- Representative of the Education providers stakeholder group - Alex Eniu, European School of Oncology (ESO)
- Representative of the Patient stakeholder group – Kathy Oliver, International Brain Tumour Alliance (IBTA)
- Representative of the Research organisations stakeholder group - Sandrine Marreaud, European Organisation for Research and Treatment of Cancer (EORTC)
- Representative of the Scientific Societies and Healthcare providers stakeholder group – Sergio Sandrucci, European Society of Surgical Oncology (ESSO)
For your further information please find herewith the latest quarterly report on the RCE initiative and a link to the RCE website: https://www.rarecancerseurope.org/